SAT0232 B-Cell Subpopulation Dynamics in Sle Patients Following Rituximab Therapy

doi 10.1136/annrheumdis-2017-eular.1704
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ Publishing Group Ltd and European League Against Rheumatism

Related search

B Cell Therapy for Rheumatoid Arthritis: The Rituximab (Anti-Cd20) Experience

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2003English

Tolerability of Obinutuzumab Therapy in Patients With Rituximab-Relapsed/Refractory B-Cell Malignancies - A Retrospective Single Center Cohort Study

Oncotarget
Oncology
2018English

The Rituximab Maintenance Therapy Improves Prognosis of Transformed Diffuse Large B Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Effect of Rituximab on B Cell Phenotype and Serum B Cell-Activating Factor Levels in Patients With Thrombotic Thrombocytopenic Purpura

Clinical and Experimental Immunology
AllergyImmunology
2015English

Rituximab Therapy in Greek Patients With Rheumatoid Arthritis

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Outcomes of Patients With Large B‐Cell Lymphomas and Progressive Disease Following CD19‐Specific CAR T‐Cell Therapy

American Journal of Hematology
Hematology
2019English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

American Journal of Hematology
Hematology
2018English

Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Anti-B Cell Therapy in Patients With Systemic Lupus Erythematosus

Modern Rheumatology Journal
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy